Century Therapeutics (IPSC) reported a third-quarter 2026 net loss of $23.5 million, compared with a $34.4 million net loss in the prior-year period. Collaboration revenue was zero for the quarter, while basic and diluted loss per share was $0.11.
The company reported $174.1 million in cash, cash equivalents and investments as of September 30, 2026, and said its cash runway extends into the first quarter of 2029.
- R&D expense was $18.1 million, down from $22.5 million a year earlier.
- G&A expense was $7.1 million, compared with $6.8 million in the prior-year quarter.
- CNTY-813 remains on track for an IND submission in the fourth quarter of 2026, with initial clinical data anticipated in the second half of 2027.
- CNTY-308 is anticipated to enter the clinic in 2026.
- Joseph Truitt was appointed to Century’s board of directors.
$IPSC Insider Trading Activity
$IPSC insiders have traded $IPSC stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $IPSC stock by insiders over the last 6 months:
- GREGORY RUSSOTTI (See Remarks) has made 0 purchases and 4 sales selling 6,229 shares for an estimated $12,961.
- DOUGLAS CARR (SVP Finance & Operations) has made 0 purchases and 6 sales selling 4,356 shares for an estimated $8,885.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$IPSC Hedge Fund Activity
We have seen 51 institutional investors add shares of $IPSC stock to their portfolio, and 34 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 6,567,346 shares (+430.8%) to their portfolio in Q2 2026, for an estimated $16,089,997
- TRAILS EDGE CAPITAL PARTNERS, LP added 4,134,969 shares (+inf%) to their portfolio in Q2 2026, for an estimated $10,130,674
- STEMPOINT CAPITAL LP added 2,146,182 shares (+inf%) to their portfolio in Q2 2026, for an estimated $5,258,145
- DV TRADING LLC added 1,400,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,430,000
- SEVEN FLEET CAPITAL MANAGEMENT LP added 1,400,000 shares (+47.5%) to their portfolio in Q2 2026, for an estimated $3,430,000
- NORTHERN TRUST CORP added 1,363,124 shares (+590.6%) to their portfolio in Q2 2026, for an estimated $3,339,653
- WOODLINE PARTNERS LP added 1,214,052 shares (+39.9%) to their portfolio in Q2 2026, for an estimated $2,974,427
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.